Display options
Share it on

Front Pharmacol. 2021 Dec 03;12:734654. doi: 10.3389/fphar.2021.734654. eCollection 2021.

Contextualising the Perceptions of Pharmacists Practicing Clinical Pharmacy in South Africa-Do We Practice what We Preach?.

Frontiers in pharmacology

Elmien Bronkhorst, Natalie Schellack, Andries G S Gous

Affiliations

  1. School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa.

PMID: 34925004 PMCID: PMC8678403 DOI: 10.3389/fphar.2021.734654

Abstract

The National Department of Health published their Quality Standards for Healthcare Establishments in South Africa and introduced the National Health Insurance, with the pilot phase that commenced in 2012. The system requires an adequate supply of pharmaceutical personnel and the direct involvement of clinical pharmacists throughout the medication-use process to ensure continuity of care, minimised risk with increasing improvement of patient outcomes. The study aimed to provide insight into the pressing issues of clinical pharmacy practice in South Africa, and sets out to contextualise the current profile of the pharmacist performing clinical functions. The study used a quantitative, explorative, cross-sectional design. The population included pharmacists from private and public tertiary hospitals. A questionnaire was administered, using Typeform™. Ethics approval was obtained from Sefako Makgatho Health Sciences University, National Department of Health and Private Healthcare groups. Categorical data were summarised using frequency counts and percentages; continuous data were summarised by mean values and standard deviations. The sample size included 70 pharmacists practicing clinical pharmacy (private sector

Copyright © 2021 Bronkhorst, Schellack and Gous.

Keywords: clinical functions; clinical pharmacy; pharmaceutical care; pharmacy education; pharmacy practice

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  1. Arch Intern Med. 2006 May 8;166(9):955-64 - PubMed
  2. Drugs Aging. 2020 Mar;37(3):161-174 - PubMed
  3. Can J Hosp Pharm. 2016 Jan-Feb;69(1):45-8 - PubMed
  4. Res Social Adm Pharm. 2021 Aug;17(8):1507-1517 - PubMed
  5. Am J Health Syst Pharm. 2010 May 1;67(9):751-6 - PubMed
  6. Lab Med. 2015 Summer;46(3):e65-71 - PubMed
  7. Res Social Adm Pharm. 2019 Jul;15(7):873-882 - PubMed
  8. Front Pharmacol. 2017 Nov 09;8:751 - PubMed
  9. Hosp Pharm. 2015 Jun;50(6):505-13 - PubMed
  10. Am J Public Health. 2016 Aug;106(8):1422-6 - PubMed
  11. Int J Clin Pharm. 2019 Apr;41(2):478-487 - PubMed
  12. Saudi Pharm J. 2014 Dec;22(6):600-2 - PubMed
  13. Clin Med (Lond). 2011 Aug;11(4):312-6 - PubMed
  14. Teach Learn Med. 2021 Oct-Dec;33(5):509-524 - PubMed
  15. Res Social Adm Pharm. 2013 Jan-Feb;9(1):80-9 - PubMed
  16. Hum Resour Health. 2015 Dec 03;13:92 - PubMed
  17. Am J Emerg Med. 2018 Oct;36(10):1727-1732 - PubMed

Publication Types